Evidence map›Paper›PMID 34398423›Full record

ArticleApplied biochemistry and biotechnology2021

Effect of Lipopeptide-Loaded Chitosan Nanoparticles on Candida albicans Adhesion and on the Growth of Leishmania major.

Siwar Soussi, Rym Essid, Ines Karkouch, Houda Saad, Sarra Bachkouel, Ezzedine Aouani, Ferid Limam, Olfa Tabbene

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Siwar SoussiLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
Rym EssidLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
Ines KarkouchLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
Houda SaadLaboratoire Des Matériaux Composites Et Minéraux Argileux, Centre National Des Recherches en Sciences Des Matériaux, BP-73, 8027, Soliman, Tunisia.
Sarra BachkouelCentre de Biotechnologie de Borj-Cedria (CBBC), Espace D'Appui À La Recherche Et de Transfert Technologique, BP-901, 2050, Hammam-lif, Tunisia.
Ezzedine AouaniLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
Ferid LimamLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
Olfa TabbeneLaboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia. tabb_olfa@yahoo.fr.ORCID http://orcid.org/0000-0002-4517-8211
Center of Biotechnogy of Borj Cédria · TNCentre de Recherches et des Technologies des Eaux · TNUniversity of Carthage · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic lipopeptides produced by Bacillus species exhibit interesting therapeutic potential. However, their clinical use remains limited due to their low stability, undesirable interactions with host macromolecules, and their potential toxicity to mammalian cells. The present work aims to develop suitable lipopeptide-loaded chitosan nanoparticles with improved biological properties and reduced toxicity. Surfactin and bacillomycin D lipopeptides produced by Bacillus amyloliquefaciens B84 strain were loaded onto chitosan nanoparticles by ionotropic gelation process. Nanoformulated lipopeptides exhibit an average size of 569 nm, a zeta potential range of 38.8 mV, and encapsulation efficiency (EE) of 85.58%. Treatment of Candida (C.) albicans cells with encapsulated lipopeptides induced anti-adhesive activity of 81.17% and decreased cell surface hydrophobicity (CSH) by 25.53% at 2000 µg/mL. Nanoformulated lipopeptides also induced antileishmanial activity against Leishmania (L.) major promastigote and amastigote forms at respective IC

Indexed as

Antifungal AgentsAntimicrobial Cationic PeptidesAntiprotozoal AgentsChitosanLipopeptidesPeptides, CyclicCandida albicansLeishmania majorNanoparticlesAntifungal AgentsAntimicrobial Cationic PeptidesAntiprotozoal Agentsbacillomycin DChitosanLipopeptidesPeptides, Cyclicsurfactin peptideAnti-adhesiveAntileishmanialChitosanLipopeptidesNanoparticles

Identifiers

PMID34398423
OpenAlexW3138348036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.